Science prac report structure

* More Science in Images
* More World Science
* Comments
* About World Science
* Tell a friend about World Science
* Supporters
* Links ( 1 , 2 , 3 )

News alerts
* Scientists still waiting for clear signs of ozone hole healing (Reuters)
* 3 in US win chemistry Nobel for computer models (AP)
* Nobel prize for Higgs boson discovery ()
* NASA Mars rover finds no sign of methane, telltale sign of life (Reuters)

Diclofenac is authorised for the relief of pain and inflammation in a wide range of conditions, including arthritic conditions and acute musculoskeletal disorders. It is currently available in the European Union (EU) in a number of different formulations. Most formulations are for systemic use (given as treatment throughout the body, such as oral and injectable medicines), which are covered by the current review. Diclofenac-containing medicines have been authorised by national approval procedures in the EU Member States and have been available for many years under a wide range of trade names.

Today, we know that a certain minimal amount of light (whether natural or artificial) has to be present for the plant to react chemically. This is called its threshold value. Despite our understanding of the basic stages and phases of phototropism, we are only now beginning to obtain the most basic knowledge of what goes on at the genetic and molecular level. We do realize however that plants are living, sensitive things that can adjust to their environment and actually seek out the light they need if they are not getting enough.

Science prac report structure

science prac report structure


science prac report structurescience prac report structurescience prac report structurescience prac report structure